Presented initial in vivo data for universal liver-targeted LNP and Wilson’s Disease program at ESGCT; initiated IND-enabling ...

H.C. Wainwright analyst Arthur He CFA maintained a Buy rating on Prime Medicine, Inc. (PRME – Research ... by a $55M upfront payment from a strategic partnership with Bristol Myers Squibb. This ...

Prime Medicine, Inc. ( (PRME) ) has released its Q3 earnings. Here is a breakdown of the information Prime Medicine, Inc. presented to its ...

Collaboration Combines Prime Medicine’s Precise, Multiplex Gene Editing Capabilities with Bristol Myers Squibb’s Broad Expertise in Development and Commercialization of Novel Cell Therapies ...

We recently compiled a list of the 10 Best Immunotherapy Stocks to Buy Now. In this article, we are going to take a look at ...

Bristol Myers Squibb Co. shares surged 12.5% Monday after rival AbbVie Inc. reported disappointing results from the trial of ...

The Bristol Myers Squibb Foundation, an independent charitable organization, has awarded Baylor College of Medicine Global Health $2.25 million for the Comprehensive Cervical Cancer Pilot Initiative ...

In this article, we are going to take a look at where Bristol-Myers Squibb Company (NYSE ... CEO of the Alliance for Regenerative Medicine (ARM), highlighted a rise in investment in cell and ...

2024 The U.S. Food and Drug Administration approved Bristol Myers Squibb's schizophrenia drug late on Thursday, making it the first new type of antipsychotic medicine in decades. Bristol Myers ...

Sanofi and Bristol-Myers Squibb have announced they are restructuring ... blood thinner Plavix and hypertension medicine Avapro/Avalide, and the arrival of generic competition in many major ...

White House says The "imposed" Eliquis price "does not reflect the substantial clinical and economic value of this essential medicine," Bristol Myers Squibb said in August. The company has said it ...

All the major pharma companies, including AstraZeneca, Bristol Myers Squibb ... In April 2024, Prime Medicine received the go-ahead from the FDA to initiate a phase I/2 trial with PE-based ...